Tama, Japan

Masayuki Nogawa

This inventor holds 1 USPTO granted patent. Top assignees: Hisamitsu Pharmaceutical Company, Inc., Rohto Pharmaceutical Co., Ltd.. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masayuki Nogawa. Retrieved from https://idiyas.com/inventor/masayuki-nogawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Biography of Masayuki Nogawa

Introduction: Masayuki Nogawa is a notable inventor based in Tama, Japan. He is recognized for his contributions to the field of pharmaceutical technology, particularly in the development of targeted drug delivery systems.

Latest Patents: Nogawa holds a patent for "Carriers targettable to organ." This innovative carrier is designed for delivering foreign substances to target organs, specifically the liver. The carrier comprises a graft copolymer where hyaluronic acid is grafted onto a polymer main chain, which has parts capable of binding to foreign substances electrostatically.

Career Highlights: Throughout his career, Masayuki Nogawa has worked with prominent companies in the pharmaceutical industry. He has been associated with Hisamitsu Pharmaceutical Company, Inc. and Rohto Pharmaceutical Co., Ltd., where he has contributed to various research and development projects.

Collaborations: During his professional journey, Nogawa has collaborated with esteemed colleagues, including Yoshiyuki Takei and Atsushi Maruyama. These collaborations have further enhanced his research and innovation in the field.

Conclusion: Masayuki Nogawa's work in targeted drug delivery systems exemplifies the intersection of innovation and healthcare. His contributions continue to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…